Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citationThe Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A.-M., Witte, O. N., & Baltimore, D. (1986) · Science · doi:10.1126/science.3460176 · Cited by 806
Duncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.053 · Cited by 732
Quantitative, High-Resolution Proteomics for Data-Driven Systems Biology
Cox, J., & Mann, M. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061308-093216 · Cited by 685
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1759 · Cited by 659
Self-citationVedadi, M., Niesen, F. H., Allali-Hassani, A., Fedorov, O. Y., Finerty, P. J., Wasney, G. A., Yeung, R., Arrowsmith, C., Ball, L. J., Berglund, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605224103 · Cited by 589
Self-citationMass Spectrometry–Based Proteomics and Network Biology
Bensimon, A., Heck, A. J. R., & Aebersold, R. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-100424 · Cited by 410
Measuring and Managing Ratio Compression for Accurate iTRAQ/TMT Quantification
Savitski, M. M., Mathieson, T., Zinn, N., Sweetman, G., Doce, C., Becher, I., Pachl, F., Kuster, B., & Bantscheff, M. (2013) · Journal of Proteome Research · doi:10.1021/pr400098r · Cited by 276
Self-citationOda, T., Heaney, C., Hagopian, J. R., Okuda, K., Griffin, J. D., & Druker, B. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31596-x · Cited by 272
Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions
Werner, T., Sweetman, G., Savitski, M. F., Mathieson, T., Bantscheff, M., & Savitski, M. M. (2014) · Analytical Chemistry · doi:10.1021/ac500140s · Cited by 258
Self-citationDetermining target engagement in living systems
Simon, G. M., Niphakis, M. J., & Cravatt, B. F. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1211 · Cited by 242
Protein folding stability and dynamics imaged in a living cell
Ebbinghaus, S., Dhar, A., McDonald, J. D., & Gruebele, M. (2010) · Nature Methods · doi:10.1038/nmeth.1435 · Cited by 234
High-Resolution Enabled TMT 8-plexing
Werner, T., Becher, I., Sweetman, G., Doce, C., Savitski, M. M., & Bantscheff, M. (2012) · Analytical Chemistry · doi:10.1021/ac301553x · Cited by 189
Self-citationDirect identification of ligand-receptor interactions on living cells and tissues
Frei, A. P., Jeon, O.-Y., Kilcher, S., Moest, H., Henning, L. M., Jost, C., Plückthun, A., Mercer, J., Aebersold, R., Carreira, E. M., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2354 · Cited by 174
Structure and Allostery of the PKA RIIβ Tetrameric Holoenzyme
Zhang, P., Smith-Nguyen, E. V., Keshwani, M. M., Deal, M. S., Kornev, A. P., & Taylor, S. S. (2012) · Science · doi:10.1126/science.1213979 · Cited by 171
Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation.
Pace, C. N., & McGrath, T. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85604-1 · Cited by 163
Erythroid Heme Biosynthesis and Its DisordersPreprint
Dailey, H. A., & Meissner, P. N. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011676 · Cited by 141
The thermodynamics of solvent exchange
Schellman, J. A. (1994) · Biopolymers · doi:10.1002/bip.360340805 · Cited by 137
Kurganov, B. I. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1015277805345 · Cited by 133
Savitski, M. M., Sweetman, G. M. A., Askenazi, M., Marto, J. A., Lang, M., Zinn, N., & Bantscheff, M. (2011) · Analytical Chemistry · doi:10.1021/ac201760x · Cited by 110
Self-citationAffinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
Becher, I., Savitski, M. M., Savitski, M. F., Hopf, C., Bantscheff, M., & Drewes, G. (2012) · ACS Chemical Biology · doi:10.1021/cb3005879 · Cited by 100
Self-citationSystems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Winter, G. E., Rix, U., Carlson, S. M., Gleixner, K. V., Grebien, F., Gridling, M., Müller, A. C., Breitwieser, F. P., Bilban, M., Colinge, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1085 · Cited by 96
Savitski, M. M., Fischer, F. F., Mathieson, T., Sweetman, G. M. A., Lang, M., & Bantscheff, M. (2010) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2010.01.012 · Cited by 90
Self-citationAsial, I., Cheng, Y. X., Engman, H., Dollhopf, M., Wu, B., Nordlund, P., & Cornvik, T. C. (2013) · Nature Communications · doi:10.1038/ncomms3901 · Cited by 88
Self-citationVemurafenib: an unusual UVA ‐induced photosensitivity
Gelot, P., Dutartre, H., Khammari, A., Boisrobert, A., Schmitt, C., Deybach, J., Nguyen, J., Seité, S., & Dréno, B. (2013) · Experimental Dermatology · doi:10.1111/exd.12119 · Cited by 84
Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines
Deguchi, Y., Kimura, S. H., Ashihara, E., Niwa, T., Hodohara, K., Fujiyama, Y., & Maekawa, T. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.11.008 · Cited by 84
Hamilton, A., Elrick, L. J., Myssina, S., Copland, M., Jørgensen, H. G., Melo, J. V., & Holyoake, T. L. (2006) · Leukemia · doi:10.1038/sj.leu.2404189 · Cited by 81
Kruse, U., Pallasch, C. P., Bantscheff, M., Eberhard, D., Frenzel, L., Ghidelli, S., Maier, S., Werner, T., Wendtner, C., & Drewes, G. (2010) · Leukemia · doi:10.1038/leu.2010.233 · Cited by 78
Self-citationZhang, L., Holmes, I. P., Hochgräfe, F., Walker, S. R., Ali, N., Humphrey, E. S., Wu, J., de Silva, M., Kersten, W. J. A., Connor, T., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr3008495 · Cited by 55
Perez, C. A., Velez, M., Raez, L. E., & Santos, E. S. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.02.001 · Cited by 49
A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal
Fraser, J. A., Madhumalar, A., Blackburn, E. A., Bramham, J., Walkinshaw, M. D., Verma, C. S., & Hupp, T. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143107 · Cited by 29
Skin Ferrochelatase and Photosensitivity in Mice and Man
Wåhlin, S., & Harper, P. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.246 · Cited by 3
Cited by
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
“By identifying off-targets TPP can be used to study possible side effects of candidate drug compounds [150].”
BackgroundIdentification of bioactive metabolites using activity metabolomics
Rinschen, M. M., Ivanisevic, J., Giera, M., & Siuzdak, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0108-4 · Cited by 1,008
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 916
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.